Skip to content
DraconiticResearch
Search Sources API
206,690 studies31 sourcesUpdated 46 min ago
Peer-reviewedCC BY-NC-NDAnnals of joint

Evaluation and management of early hip osteoarthritis.

  1. 1Department of Orthopaedic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  2. 2Department of Orthopedic Surgery, Washington University St. Louis, St. Louis, MO, USA.

Abstract

The early stages of hip osteoarthritis (OA) remain less clearly defined, particularly regarding the optimal therapeutic interventions to slow or prevent disease progression. This review synthesizes current evidence on the diagnosis and management of early hip OA, with an emphasis on hip preservation techniques. Initial management typically involves conservative measures, including nonsteroidal anti-inflammatory drugs (NSAIDs), physical therapy, and corticosteroid injections. For select patients, modern surgical hip preservation techniques such as hip arthroscopy and peri-acetabular osteotomy (PAO) offer promising outcomes by preserving joint integrity and delaying or preventing the need for arthroplasty. Proper patient selection is critical for optimizing outcomes, with factors such as age, severity of arthritis, and baseline function influencing treatment success. Hip arthroscopy yields favorable results in patients with minimal joint space narrowing, Tönnis grade less than or equal to one, and mild chondral damage. PAO is most effective in younger patients with acetabular dysplasia and minimal arthritic changes. Although hip resurfacing arthroplasty remains an option for young, active male patients with good bone quality, concerns about complications have limited its use. Total hip arthroplasty (THA) remains the gold standard for advanced disease but may have less predictable outcomes in patients with minimal radiographic changes. Shared decision-making and thorough preoperative counseling are essential to set realistic patient expectations and guide treatment decisions. To that end, this review underscores the importance of a patient-centered approach in managing early hip OA to optimize outcomes and satisfaction.

Related

  1. Knee osteoarthritis management across the joint-preservation continuum: current evidence and future directions
    Joshua Kulpinski, Andrew Carusi, Michael Langworthy
    Frontiers in surgeryPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  2. Management of Advanced Tricompartmental Knee Osteoarthritis With Degenerative Meniscal Pathology Using Extracorporeal Magnetotransduction Therapy, Extracorporeal Shockwave Therapy, Microfragmented Adipose Tissue, and Platelet-Rich Plasma
    Aneesh Garg, Spencer Decker, Micky Nguyen
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Comparative effectiveness of exercise and self-management interventions delivered through different modes of digital support on pain and patient-reported physical function in people with knee osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials
    Hao Luo, Guoqing Zhang, Lingyun Long +3
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Radiologic Progression of Early-Stage Ankle Osteoarthritis: A Mean 12-Year Follow-up Observational Study
    Myoung Yeol Shin, Jae Hyeon Seo, Young Kwan Moon +3
    Clinics in orthopedic surgeryPeer-reviewedCC BY-NCFull textSurgery & anaesthesiaEurope PMC
  5. The Stanford Knee Osteoarthritis PET/MRI Evaluation (SKOPE) Study Protocol
    A. Goyal, Y. Vainberg, R. Shalit +2
    medRxivPreprintAll rights reservedFull text1 citedMedical imaging & radiologymedRxiv
BibTeX
@article{lunn2026evaluation,
  title = {{Evaluation and management of early hip osteoarthritis.}},
  author = {Kiera Lunn and Jeremy Huckleby and Cortez L Brown and Emelia Krakora and Henson Destine and Dharmesh Vyas and Justin J Hicks},
  journal = {Annals of joint},
  year = {2026},
  month = oct,
  doi = {10.21037/aoj-25-61},
  url = {https://europepmc.org/article/MED/42999507},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Evaluation and management of early hip osteoarthritis.
AU  - Kiera Lunn
AU  - Jeremy Huckleby
AU  - Cortez L Brown
AU  - Emelia Krakora
AU  - Henson Destine
AU  - Dharmesh Vyas
AU  - Justin J Hicks
PY  - 2026
DA  - 2026/10/26
JO  - Annals of joint
DO  - 10.21037/aoj-25-61
UR  - https://europepmc.org/article/MED/42999507
AB  - The early stages of hip osteoarthritis (OA) remain less clearly defined, particularly regarding the optimal therapeutic interventions to slow or prevent disease progression. This review synthesizes current evidence on the diagnosis and management of early hip OA, with an emphasis on hip preservation techniques. Initial management typically involves conservative measures, including nonsteroidal anti-inflammatory drugs (NSAIDs), physical therapy, and corticosteroid injections. For select patients, modern surgical hip preservation techniques such as hip arthroscopy and peri-acetabular osteotomy (PAO) offer promising outcomes by preserving joint integrity and delaying or preventing the need for arthroplasty. Proper patient selection is critical for optimizing outcomes, with factors such as age, severity of arthritis, and baseline function influencing treatment success. Hip arthroscopy yields favorable results in patients with minimal joint space narrowing, Tönnis grade less than or equal to one, and mild chondral damage. PAO is most effective in younger patients with acetabular dysplasia and minimal arthritic changes. Although hip resurfacing arthroplasty remains an option for young, active male patients with good bone quality, concerns about complications have limited its use. Total hip arthroplasty (THA) remains the gold standard for advanced disease but may have less predictable outcomes in patients with minimal radiographic changes. Shared decision-making and thorough preoperative counseling are essential to set realistic patient expectations and guide treatment decisions. To that end, this review underscores the importance of a patient-centered approach in managing early hip OA to optimize outcomes and satisfaction.
SN  - 2415-6809
ER  -